Sort
141,003 grants matching “cytokine”
Biomarker Investigations for Clinical Trials
$1,025,905Liang Cao · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA
A Randomized Controlled Trial of Prophylaxis with Direct-acting Antivirals for Kidney Transplantation from Hepatitis C virus-infected donor to Uninfected Recipients (PREVENT-HCV)
$1,025,696Christine Marie Durand · Johns Hopkins University · U01 · FY2022 · AI
Immunological Analysis of Brain Cancer
$1,025,686Masaki Terabe · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
An innovative, non-thiazolidinedione pan-PPAR agonist therapeutic for alcoholic hepatitis: IND-enabling safety and toxicological evaluation
$1,025,643Prasad Manchem · Pleiogenix Inc. · R44 · FY2025 · AA
Transvriptional Control in Macrophage Response to Pathogens
$1,025,084Alan A Aderem · University Of Washington · U54 · FY2012 · AI
Intersection of Neuro-Immune-Vascular Dynamics in Preclinical NeuroHIV Model
$1,025,015Irene Munk Pedersen · Scintillon Institute For Photobiology · R61 · FY2025 · NS
Intratumoral immunotherapy with formulated resiquimod for metastatic melanoma
$1,024,973Yen Tun Wang · Curebiotech, Inc. · R44 · FY2019 · CA
Dissecting innate immune control of intestinal and systemic Yersinia infection
$1,024,897Igor E Brodsky · University Of Pennsylvania · R01 · FY2025 · AI
The Thrifty Microbiome: The Role of the Gut Microbiota in Obesity in the Amish
$1,024,737Claire M Fraser-Liggett · University Of Maryland Baltimore · UH2 · FY2009 · DK
Novel Interactions Between the Immune and Neuroendocrine Systems
$1,024,566Dennis D. Taub · National Institute On Aging · Z01 · FY2008 · AG
NADPH Oxidases as Novel Targets for Cancer Therapy
$1,024,528James Doroshow · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Retroviral genetic modification of PBLs to optimize expansion for cell therapy
$1,024,494Nicholas Klemen · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Human EGFRvIII-specific BiTE for the treatment of Glioblastoma
$1,024,390John H Sampson · Duke University · U01 · FY2016 · NS
The UIUC Neuroproteomics Center on Cell-Cell Signaling
$1,023,849University Of Illinois Urbana-Champaign · P30 · FY2005 · DA
Development of Novel Approaches to Optimize CAR T-cell Therapies for B-cell Malignancies
$1,023,609Nirali Shah · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Pathophysiology of Acute Pain in Patients with Sickle Cell Disease
$1,023,525Swee Lay Thein · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Host Directed Orynotide for MDR Gram Negative Bacterial Infections
$1,023,350Justin Blaine Schaal · University Of Southern California · R01 · FY2025 · AI
Studies of Chemokine-Receptor Interactions with Chemokines and alarmins
$1,023,149Joost J Oppenheim · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Path to Commercialization of the first âoff the shelfâ T cell product
$1,022,567John Wilson · Viracyte, Llc · R44 · FY2019 · HL
Development of VNPP433-3Beta as Novel Therapeutic for All Stages of Prostrate Cancer
$1,022,522Vidya P Ramamurthy · Isoprene Pharmaceuticals, Inc. · R44 · FY2025 · CA
Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer
$1,022,419Stuart H. Yuspa · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis
$1,022,419Stuart H. Yuspa · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
RNAi Screening in Hematopoietic Cells
$1,022,358Iain Fraser · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Analysis of Innate Immune Signaling Networks
$1,022,358Iain Fraser · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Role of B Lymphocytes In HIV Infection And Pathogenesis
$1,022,245Susan Moir · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI